RecruitingNot ApplicableNCT07056582
Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries
Sponsor
Sohag University
Enrollment
105 participants
Start Date
Apr 14, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
this study aims to compare the efficacy of pre-emptive nebulized ketamine versus nebulized dexmedetomidine for post operative pain relief in endoscopic nasal surgery
Eligibility
Min Age: 20 YearsMax Age: 60 Years
Inclusion Criteria4
- patients between the ages of 20 and 60,
- both sexes,
- American Society of Anesthesiologists physical status I to II
- BMI ≥18≤30 kg/m²
Exclusion Criteria5
- Patient refusal.
- patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
- patients with a history of allergies to any study drugs.
- patients who had used central nervous system depressants or analgesics within the previous 24 hours.
- patients with hypertension, hypotension, or bradycardia.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexmedetomidine
patients in this group will receive nebulized Dexmedetomidine before onset of surgery
DRUGKetamine
patients in this group will receive nebulized ketamine before onset of surgery
DRUG0.9%sodium chloride
patients in this group will receive nebulized 0.9% normal saline before onset of surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07056582